The lung immune prognostic index as a predictive biomarker in urological malignancies undergoing immune checkpoint inhibitor therapy

Objective We conducted a meta-analysis to evaluate the prognostic utility of the Lung Immune Prognostic Index (LIPI) in patients with urological malignancies treated with immune checkpoint inhibitors (ICIs).Methods We systematically searched PubMed, the Cochrane Library, and EMBASE up to March 3, 20...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yan He, Yuan Yuan, Xiao Wei, Lili Li, Pengcheng Luo
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Taylor & Francis Group 2025-12-01
Colección:	Annals of Medicine
Materias:	Lung Immune Prognostic index (LIPI) immune checkpoint inhibitors (ICIs) urological malignancies meta-analyses
Acceso en línea:	https://www.tandfonline.com/doi/10.1080/07853890.2025.2582907
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!